AUSTRALIAN PRODUCT RECALL

Dostinex, Cabaser and Methoblastin

Published 12 March 2015

Product

Prescription medications Identifying features description Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8 AUST R number: 52158 Cabaser (cabergoline) 1 mg tablet, bottles of 30 AUST R number: 57360 Cabaser (cabergoline) 2 mg tablet, bottles of 30 AUST R number: 57367 METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30 AUST R number: 15418 METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50 AUST R number: 15417

Why it was recalled

The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.

Hazard

If children gain access to the products there is the potential for inadvertent poisoning.

Read the official notice ↗

Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.